{"id":"NCT01143077","sponsor":"Sumitomo Pharma America, Inc.","briefTitle":"A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents","officialTitle":"A Randomized, 6-week, Open-Label, Study Evaluating The Safety, Tolerability, and Efficacy of Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-06","primaryCompletion":"2011-05","completion":"2011-05","firstPosted":"2010-06-14","resultsPosted":"2012-08-16","lastUpdate":"2013-04-17"},"enrollment":244,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Schizophrenia","Schizoaffective Disorder"],"interventions":[{"type":"DRUG","name":"Lurasidone HCl","otherNames":["Latuda"]}],"arms":[{"label":"Lurasidone Open-Label Arm A","type":"EXPERIMENTAL"},{"label":"Lurasidone Open-Label Arm B","type":"EXPERIMENTAL"},{"label":"Lurasidone Open-Label Arm C","type":"EXPERIMENTAL"}],"summary":"Lurasidone (lurasidone HCl) is a novel psychotropic agent that is being developed as a potential new antipsychotic treatment for patients with schizophrenia. Switching between antipsychotic medications is common in the treatment of schizophrenia. The current study is designed to evaluate the effectiveness, safety, and tolerability of switching clinically stable, but symptomatic outpatients with schizophrenia or schizoaffective disorder from their preswitch antipsychotic medication to lurasidone, over a period of 6 weeks.","primaryOutcome":{"measure":"Time to Relapse of Psychotic Symptoms During 6 Weeks","timeFrame":"6 Weeks","effectByArm":[{"arm":"Lurasidone Open-Label Arm 40/40","deltaMin":23.8,"sd":12.1},{"arm":"Lurasidone Open-Label Arm 40/80","deltaMin":16.9,"sd":11.6},{"arm":"Lurasidone Open-Label Arm 80/80","deltaMin":17.3,"sd":8.9}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":27,"countries":["United States"]},"refs":{"pmids":["23473350","24559217"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":72},"commonTop":["Nausea","Insomnia","Akathisia","Headache","Vomiting"]}}